Structuring Cross-Border Tech and Life Sciences Deals with China

Presented as part of the 2026 China Law Symposium, this panel explores how technology and life sciences companies structure, negotiate, and execute complex cross-border deals involving China and the broader Asia-Pacific region. Drawing on deep experience in regulatory strategy, licensing, and collaboration agreements, the speakers will discuss how legal, IP, and regulatory considerations shape transaction design—from pre-market approval to long-term partnership governance. The discussion will offer practical insights for navigating regulatory uncertainty while aligning commercial and innovation goals across jurisdictions.

Panelists include:

John C. Balzano, Partner at Covington & Burling’s New York office with over twenty years of experience in China/APAC regulatory issues, including NMPA and SAMR compliance; 

Weishi Li, a former Covington partner and registered U.S. patent attorney specializing in life sciences collaborations and cross-border licensing; 

Joanna Wu, Head of Operations and General Counsel, U.S., at NovaBridge Biosciences with extensive experience in the biotech industry; and 

Jerry Xia, a Founding Partner of GEN Law Firm. Mr. Xia co-chairs the firm’s patent and trade secret practices and has over 20 years of experience in private and in-house practice.

Registration Form

Lunch will be provided.